Mixed earnings forecast for Big Pharma

It's a solid earnings forecast for some of the pharma and biotech industry's biggest players who report fourth-quarter results this week. But for a few, the numbers are being driven by cost-cutting instead of sales growth.

Read More...

[Source: Financial news of the day - CNNMoney.com]